Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease
© 2020 Wiley Periodicals LLC..
We have modeled modifications of a known ligand to the SARS-CoV-2 (COVID-19) protease, that can form a covalent adduct, plus additional ligand-protein hydrogen bonds.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Proteins - 88(2020), 12 vom: 30. Dez., Seite 1557-1558 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lesk, Arthur M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acetylcholinesterase |
|---|
| Anmerkungen: |
Date Completed 09.11.2020 Date Revised 16.07.2022 published: Print-Electronic CommentOn: PLoS One. 2009;4(2):e4349. - PMID 19194505 Citation Status MEDLINE |
|---|
| doi: |
10.1002/prot.25980 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312395027 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312395027 | ||
| 003 | DE-627 | ||
| 005 | 20231225144326.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/prot.25980 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1041.xml |
| 035 | |a (DE-627)NLM312395027 | ||
| 035 | |a (NLM)32662915 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lesk, Arthur M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2020 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: PLoS One. 2009;4(2):e4349. - PMID 19194505 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals LLC. | ||
| 520 | |a We have modeled modifications of a known ligand to the SARS-CoV-2 (COVID-19) protease, that can form a covalent adduct, plus additional ligand-protein hydrogen bonds | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a active-site ligand | |
| 650 | 4 | |a modeling | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Insecticides |2 NLM | |
| 650 | 7 | |a Protease Inhibitors |2 NLM | |
| 650 | 7 | |a Viral Nonstructural Proteins |2 NLM | |
| 650 | 7 | |a Acetylcholinesterase |2 NLM | |
| 650 | 7 | |a EC 3.1.1.7 |2 NLM | |
| 650 | 7 | |a Cysteine Endopeptidases |2 NLM | |
| 650 | 7 | |a EC 3.4.22.- |2 NLM | |
| 700 | 1 | |a Konagurthu, Arun S |e verfasserin |4 aut | |
| 700 | 1 | |a Allison, Lloyd |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia de la Banda, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Stuckey, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Abramson, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Proteins |d 1988 |g 88(2020), 12 vom: 30. Dez., Seite 1557-1558 |w (DE-627)NLM012942030 |x 1097-0134 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2020 |g number:12 |g day:30 |g month:12 |g pages:1557-1558 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/prot.25980 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2020 |e 12 |b 30 |c 12 |h 1557-1558 | ||